Advanced or Metastatic Gastric Cancer
5 clinical trials · Condition
◉ Watch Advanced or Metastatic Gastric Cancer
| Record | Firm | Date |
|---|---|---|
| BC001 in Combination with Sintilimab and XELOX in the Treatment of HER-2 Negative Advanced or Metastatic Gastric Cancer or Gastroesophageal Junction Adenocarcinoma. (NCT06773312) | Sichuan Luzhou Buchang Biopharmaceutical Co., Ltd. | 2025-02-28 |
| A Study of MRG002 in Patients with HER2-Positive Advanced Solid Tumors and Locally Advanced or Metastatic Gastric/Gastroesophageal Junction (GEJ) Cancer (NCT04492488) | Shanghai Miracogen Inc. | 2021-05-24 |
| A Study to Evaluate the Efficacy and Safety of MRG003 in Patients With Advanced Gastric Cancer. (NCT05188209) | Shanghai Miracogen Inc. | 2021-05-24 |
| Study of Metatinib Tromethamine Tablet (NCT02650375) | Jiangsu Simcere Pharmaceutical Co., Ltd. | 2015-10-01 |
| Phase III Study of Apatinib Tablets in the Treatment of Advanced or Metastatic Gastric Cancer (NCT01512745) | Jiangsu HengRui Medicine Co., Ltd. | 2011-01-01 |
Track Advanced or Metastatic Gastric Cancer automatically
Every clearance here is in the API, with alerts when new ones post.